Evidence map›Paper›PMID 39618627›Full record

ArticleCureus2024

Plasmapheresis as an Ischaemic Stroke Treatment: A Rare Case of Acquired Thrombotic Thrombocytopenic Purpura.

Francisco Barreto, Sofia Nóbrega, Rui Fernandes, Carolina I Carvalhinha, Teresa Faria

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Francisco BarretoInternal Medicine, Hospital Central do Funchal, Funchal, PRT.
Sofia NóbregaInternal Medicine, Hospital Central do Funchal, Funchal, PRT.
Rui FernandesInternal Medicine, Hospital Central do Funchal, Funchal, PRT.
Carolina I CarvalhinhaInternal Medicine, Hospital Central do Funchal, Funchal, PRT.
Teresa FariaInternal Medicine, Hospital Central do Funchal, Funchal, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acquired thrombotic thrombocytopenic purpura (acquired TTP) is a rare clinical syndrome caused by a decreased ADAMST13 activity, leading to systemic microvascular thrombotic events, with high mortality rates when the diagnosis and treatment are delayed. The authors report an acquired TTP in a patient with cerebrovascular disease. The aim is to emphasize the importance of considering atypical acquired TTP clinical presentations in order to optimize diagnostic and treatment approaches, minimize possible sequels, and improve the prognosis.

Indexed as

acquired thrombotic thrombocytopenic purpuraadamts13 activityplasmapheresisstrokethrombotic microangiopathy

Identifiers

PMID39618627
PMCPMC11608012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.